Text this: Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

             ___               _    _    _    _   
    ___     / _ \\      ___   | || | || | || | || 
   /   ||  | / \ ||    /   || | || | || | || | || 
  | [] ||  | \_/ ||   | [] || | \\_/ || | \\_/ || 
   \__ ||   \___//     \__ ||  \____//   \____//  
    -|_||   `---`       -|_||   `---`     `---`   
     `-`                 `-`